Start › Niedrobnokomórkowy rak płuca › Colorado › Aurora
Badania kliniczne dla Niedrobnokomórkowy rak płuca w mieście Aurora, CO
31 badań dla Niedrobnokomórkowy rak płuca szuka uczestników w ośrodkach w mieście Aurora i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
RekrutacjaFaza 1/2
- University Of Colorado - Anschutz Medical Campus /ID# 269069, Aurora
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekrutacjaFaza 3
- Rocky Mountain Cancer Centers-Aurora, Aurora
- UCHealth University of Colorado Hospital, Aurora
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- University of Colorado, Aurora
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
RekrutacjaFaza 3
- University of Colorado Anschutz Medical Campus ( Site 0151), Aurora
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
RekrutacjaFaza 3
- University of Colorado Cancer Center ( Site 3268), Aurora
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RekrutacjaFaza 3
- Rocky Mountain Cancer Centers LLP, Aurora
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RekrutacjaFaza 1/2
- Rocky Mountain Cancer Centers,LLP, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekrutacjaFaza 1/2
- University of Colorado Cancer Center, Aurora
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekrutacjaFaza 1
- University of Colorado Cancer Center, Aurora
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RekrutacjaFaza 3
- Clinical Study Site, Aurora
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekrutacjaFaza 1/2
- University of Colorado - Aurora Cancer Center, Aurora
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekrutacjaFaza 2/3
- Local Institution - 007-872-H, Aurora
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekrutacjaBadanie obserwacyjne
- University of Colorado, Aurora
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
RekrutacjaFaza 1/2
- UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekrutacjaFaza 1
- University of Colorado Cancer Center, Aurora
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- University of Colorado Health Hospital, Aurora
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RekrutacjaFaza 1
- University of Colorado Cancer Center, Aurora
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
RekrutacjaFaza 3
- University of Colorado Health, Aurora
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- University of Colorado, Aurora
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
RekrutacjaFaza 1/2
- University of Colorado Cancer Center, Aurora
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RekrutacjaFaza 1
- University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora
- University of Colorado Hospital, Aurora
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- UCHealth University of Colorado Hospital, Aurora
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
RekrutacjaBadanie obserwacyjne
- University of Colorado Hospital, Aurora
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Rocky Mountain Regional VA Medical Center, Aurora
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- UCHealth University of Colorado Hospital, Aurora
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
RekrutacjaFaza 1/2
- University of Colorado Cancer Center, Aurora
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekrutacjaBadanie obserwacyjne
- Rocky Mountain Cancer Centers-Aurora, Aurora
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
RekrutacjaBadanie obserwacyjne
- University of Colorado, Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekrutacjaBadanie obserwacyjne
- Massive Bio SYNERGY-AI site, Aurora
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
RekrutacjaBadanie obserwacyjne
- University of Colorado Cancer Center at UC Health Sciences Center, Aurora
A Study of NX-1607 in Adults With Advanced Malignancies
RekrutacjaFaza 1
- University of Colorado School of Medicine, Aurora
Badania dla Niedrobnokomórkowy rak płuca w innych miastach
- Houston, TX145 badań
- New York City, NY121 badań
- Arlington, VA104 badań
- Nashville, TN97 badań
- Boston, MA90 badań
- Los Angeles, CA87 badań
- St. Louis, MO73 badań
- Chicago, IL61 badań
- Baltimore, MD60 badań
- San Antonio, TX59 badań
- Columbus, OH57 badań
- Washington, DC55 badań
Inne badania w mieście Aurora
- Nowotwory (wszystkie typy)35 badań
- Rak jelita grubego i odbytnicy32 badań
- Rak piersi28 badań
- Rak jajnika25 badań
- Nowotwór przerzutowy25 badań
- Cukrzyca typu 123 badań
- Otyłość22 badań
- Rak prostaty19 badań
- Rak płuc19 badań
- Niewydolność serca18 badań
- Czerniak18 badań
- Ostra białaczka szpikowa16 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.